This inventor holds 2 USPTO granted patents. Top assignee: Cantab Pharmaceuticals Research Limited. Active years: 1999-2000.
Company Filing History:
Years Active: 1999-2000
Title: Jeremy Paddon Carmichael: Innovator in Immunotherapeutic Agents
Introduction
Jeremy Paddon Carmichael, based in Belfast, GB, is an accomplished inventor known for his significant contributions to the field of immunotherapy. With a total of two patents to his name, Carmichael is making strides in the development of novel polypeptides that play a crucial role in combating viruses.
Latest Patents
Carmichael's latest innovations include groundbreaking patents focused on polypeptides that are useful as immunotherapeutic agents. His two patents describe fusion polypeptides and aggregates of polypeptides comprising papillomavirus-derived antigens. These compositions are particularly geared towards eliciting HPV-specific immune responses, utilizing adjuvants for immunogenic and vaccine purposes. Notably, the polypeptides can be purified to create aggregates capable of passing through sterilization filters, allowing for the development of effective vaccine formulations. An example includes a fusion protein of human papillomavirus proteins L2 and E7, highlighting the innovative approaches Carmichael is employing in his research.
Career Highlights
Carmichael is associated with Cantab Pharmaceuticals Research Limited, where he contributes to advancing the understanding of immunotherapeutic agents. His work is essential in the context of developing effective treatments against virally induced diseases, focusing on harnessing the body's immune response to target specific pathogens.
Collaborations
Throughout his career, Carmichael has collaborated with esteemed professionals, including Nigel Richard Whittle and Stephen Edward Connor. These collaborations aim to amplify the impact of their research, leveraging collective expertise to push the boundaries of immunotherapy.
Conclusion
Jeremy Paddon Carmichael's innovative work in the field of immunotherapeutic agents is positioning him as a vital figure in medical research. With his patents reflecting significant advancements in immunology, he continues to contribute towards the development of effective treatments aimed at improving public health outcomes. His efforts underscore the importance of collaboration and innovation in tackling complex health challenges.